In tissue samples from patients with SD or PD, IL2RG (IL-2 receptor subunit gamma) was differentially expressed after treatment, which was previously identified to contribute in pancreatic cancer growth [65]. This evidence concerns the gene IL2RG and familial pancreatic carcinoma.